
### [Orphanet:308459](http://www.orpha.net/ORDO/Orphanet_308459)
**Label:** Disorder of glycolysis

**Subclasses:** [Orphanet:79299](http://www.orpha.net/ORDO/Orphanet_79299) (Hyperinsulinism due to glucokinase deficiency), [Orphanet:868](http://www.orpha.net/ORDO/Orphanet_868) (Triose phosphate-isomerase deficiency), [Orphanet:712](http://www.orpha.net/ORDO/Orphanet_712) (Hemolytic anemia due to glucophosphate isomerase deficiency), 

**Corr. equiv. classes:** [OMIM:602485](http://purl.obolibrary.org/obo/OMIM_602485), [OMIM:615512](http://purl.obolibrary.org/obo/OMIM_615512), [Orphanet:712](http://www.orpha.net/ORDO/Orphanet_712), [Orphanet:868](http://www.orpha.net/ORDO/Orphanet_868), [Orphanet:79299](http://www.orpha.net/ORDO/Orphanet_79299), [OMIM:613470](http://purl.obolibrary.org/obo/OMIM_613470), 

**Class expressions from DL-Learner:**

- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0009830](http://purl.obolibrary.org/obo/HP_0009830) (Peripheral neuropathy) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0012437](http://purl.obolibrary.org/obo/HP_0012437) (Abnormal gallbladder morphology) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 66.67%


